FASLG and esophageal cancer: For the FasL -844C>T polymorphism, the -844CC associated with increased cancer risk was observed in gastric cancer, esophageal cancer, and ovarian cancer among the previous studies, indicating that this polymorphism had similar effect on these three cancers.